Consultation on laboratory capacity building for malaria diagnosis in the EU/EEA
The consultation aimed to assess the needs and requirements of laboratory capacity building initiatives for malaria parasite laboratory testing in the EU/EEA.
Declining incidence of imported malaria in the Netherlands, 2000-2007Archived
This descriptive study, based on national surveillance data of reported malaria cases, travelers’ statistics and data on malaria chemoprophylaxis prescriptions, estimates the incidence and trends of imported malaria in the Netherlands.
Artesunate versus quinine in the treatment of severe falciparum malaria malaria in African children (AQUAMAT): an open-label, randomized trialArchived
This paper describes the results of an open-label randomized trial, comparing the use of artesunate and quinine for the treatment of severe Plasmodium falciparum malaria in children in 11 African countries.
Artemisinin resistance: the clock is tickingArchived
Artemisinin resistance in falciparum malaria has emerged in western Cambodia exactly where chloroquine resistance arose 50 years ago. Similarly to the resistance to chloroquine that spread to Africa, the experts are wondering whether artemisinin resistance will spread as widely. In such a case the consequences would be disastrous.
Case Report: Imported Plasmodium knowlesi Malaria in a French Tourist Returning from ThailandArchived
The authors describe a case of imported Plasmodium knowlesi infection in a French tourist acquired in Thailand. The patient had spent a three month beach holiday on the west coast of Thailand including a one month stay on the Island of Ko Payam.
Severe Imported Plasmodium falciparum Malaria, France 1996-2003Archived
Using surveillance data obtained from 21,888 imported Plasmodium falciparum cases in France during 1996-2003, factors independently associated with severe malaria (832 cases; ≈3.8%) were older age, European origin, travel to eastern Africa, absence of chemoprophylaxis, initial visit to a general practitioner, time to diagnosis of 4 to 12 days, and diagnosis during the fall-winter season.
Scientific advances – Intravenous artesunate for severe Malaria in Travelers, EuropeArchived
This study describes the outcome of 25 travellers with severe malaria who returned from malaria-endemic regions and were treated at 7 centres in Europe with intravenous artesunate. Among these 25 patients, one child and 24 adults (mean ± SD age 44.1 ± 16.1 years), 10 patients received the dosing regimen for artesunate initially recommended by WHO and 11 received artesunate, 2.4 mg/kg/dose.
Expert opinion: Is screening for malaria necessary among asymptomatic refugees and immigrants coming from endemic countries?Archived
This article assesses the findings of a recent Canadian study which measured malaria prevalence among recently arrived asymptomatic refugees.